NK Cells therapy (Boe Technology Group)

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameNK Cells therapy (Boe Technology Group)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy

Mechanisms of ActionNatural killer cell replacements

TargetsNot applicable

Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBeijing Orient Sci Tech Group

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Orient Sci Tech Group

Inactive CompaniesN/A

Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A